English
SpanishTrusted Resources: Community Center
Online groups, photo galleries and blogs
Innovation in Child Neurology: Acadia’s Head of Rare Disease Shares What It Takes to Make a Breakthrough
Kathie Bishop, Ph.D., knows exactly what it takes to lead cutting-edge therapeutics for neurologic and rare diseases from research to development to changing lives for patients and their families.
She is the Senior Vice President, Chief Scientific Officer and Head of Rare Disease at Acadia Pharmaceuticals – a role that was created specifically for her when she joined the company nearly a year ago in January 2021.
BookmarkRelated Content
-
Family History Can Be Key in Identifying Silent Carriers of SMAA family and medical history examination...
-
John Hopkins – Spinal Muscular Atrophy (SMA) CenterThe Spinal Muscular Atrophy (SMA) Center...
-
An Interview With Muscular Dystrophy Association President Donald S. WoodLarry Luxner, senior correspondent for R...
-
mySMAteam – FacebookmySMAteam is the social network for thos...
-
Community Connections: Khi Ellison Living With SMAA Maumelle woman living with a rare gene...
-
Muscular Dystrophy AssociationMDA's legacy of progress has always star...
-
Burden of Proof: The Privilege of My Visible DisabilityWhen I enter a room, my disability is al...
